NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

兔熱病的全球市場:各產品、各技術、檢驗的各類型、各病原體、各地區 - 市場規模、佔有率、預測,新型冠狀病毒感染疾病 (COVID-19)的影響 (2021年∼2027年)

Tularemia Market with COVID-19 Impact Analysis, By Product, By Technology, By Test Type, By Pathogen and By Region - Size, Share, & Forecast from 2021-2027

出版商 AnalystView Market Insights 商品編碼 980686
出版日期 內容資訊 英文 208 Pages
商品交期: 2-3個工作天內
價格
兔熱病的全球市場:各產品、各技術、檢驗的各類型、各病原體、各地區 - 市場規模、佔有率、預測,新型冠狀病毒感染疾病 (COVID-19)的影響 (2021年∼2027年) Tularemia Market with COVID-19 Impact Analysis, By Product, By Technology, By Test Type, By Pathogen and By Region - Size, Share, & Forecast from 2021-2027
出版日期: 2020年12月01日內容資訊: 英文 208 Pages
簡介

全球兔熱病市場2020年價值2億3080萬美元,從2021年到2027年的預測期間內預計以6.3%的年複合成長率的成長。各地區中北美是最大的市場,其次是歐洲各國。

本報告提供全球兔熱病醫藥品的市場相關分析,市場定義和基本結構,主要的推動及阻礙市場要素,產業的競爭力、向心力,市場佔有率結構,各產品、各技術、檢驗的各類型、各病原體、各地區的市場趨勢預測 (過去5年、今後7年份),主要企業的簡介,新型冠狀病毒感染疾病 (COVID-19)的影響等調查。

目錄

第1章 兔熱病:市場概要

第2章 摘要整理

第3章 兔熱病市場:主要的市場趨勢

  • 推動市場要素
    • 推動市場要素的影響度分析
  • 阻礙市場要素
    • 阻礙市場要素的影響度分析
  • 市場機會
  • 未來市場趨勢

第4章 兔熱病市場:產業研究

  • 波特的五力分析
  • 行銷策略分析
  • 市場成長預測:製圖
  • 管理體制分析

第5章 兔熱病市場:新型冠狀病毒感染疾病 (COVID-19)的影響分析

  • "COVID-19前" 的影響分析
  • "COVID-19後" 的影響分析
    • 高業績市場區隔
    • 邊際成長市場區隔
    • 低業績市場區隔
    • 邊際損失市場區隔

第6章 兔熱病市場:市場環境

  • 市場佔有率分析 (2019年)
  • 主要的技術創新企業的分析
  • 市場區隔資料:各主要製造商
    • 現有企業分析
    • 新企業分析

第7章 兔熱病市場:各類型

  • 概要
  • 腺性兔熱病
  • 中咽兔熱病
  • 潰瘍腺性兔熱病
  • Pneumatic兔熱病
  • 其他

第8章 兔熱病市場:各診斷技術

  • 概要
  • 免疫化學
  • 顯微鏡檢驗
  • 其他

第9章 兔熱病市場:各藥物

  • 概要
  • Gentamycin
  • Streptomycin
  • Ciprofloxacin
  • Doxycycline
  • 其他

第10章 兔熱病市場:各終端用戶

  • 概要
  • 真菌性敗血症
  • 細菌性敗血症
  • 其他

第11章 兔熱病市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第12章 供應商分析

  • 競爭儀表板
  • 企業簡介
    • Pfizer Inc.
    • Zydus Cadila
    • GlaxoSmithKline plc
    • Apotex Inc.
    • Alkem Labs
    • Sun Pharmaceutical Industries Ltd.
    • Mylan Pharmaceuticals Inc.
    • Allergan
    • Thermo Fisher Scientific Inc.
    • Piramal Enterprises Ltd.
    • Bayer AG.
    • Cipla Inc.
    • Lupin Pharmaceuticals Inc.

第13章 分析師的全方位分析

第14章 附錄

目錄

REPORT HIGHLIGHT

The global Tularemia market was valued at USD 230.8 million in 2020, growing with 6.3% CAGR during the forecast period, 2021-2027.

Tularemia is a kind of infectious disease that is caused by bacteria called Francisella tularensis. Various symptoms of tularemia are shortness of breathing, joints & muscle aches, chest pain, swollen lymph glands in the neck, cough, and headache. Tularemia disease mainly occurs in North America, Europe, and the Asia region.

The tularemia market is anticipated to grow at a significant rate in the next few years, owing to the rising number of developments in novel drugs. According to the data of the European center for disease prevention and control, the number of cases from tularemia is around 800 per year. Antibiotics are generally given to the patients of Tularemia. Treatment for tularemia normally lasts for 10-21 days depending on medication requirement. Tularemia disease is highly contagious and may cause death. Several causes including tick bites and exposure to sick or dead animals are responsible for tularemia. Tularemia is caused by different factors such as eating undercooked meat, airborne infection.

Furthermore, the introduction of novel drugs, the development of therapeutic approaches are boosting the growth of the tularemia market. The rising number of tularemia cases across developing countries is contributing to tularemia treatment. According to CDC data, in 2016, around 230 cases of tularemia were found in the U.S. Thus, lack of safe and effective vaccine availability is hindering the market growth. Moreover, stiff regulations regarding the approval of drugs are also impacting market growth.

According to the CDC data, the mortality for tularemia disease is lower than 2.0% and may go up to 24.0% based on strain. The people working in laboratories of tularemia are at great risk of airborne infection through pathogens. If the tularemia treatment is not carried at right time it may cause other disorders such as enlarged liver, enlarged spleen, infection around the heart, spinal cord. This may result in death.

North America held the largest market share in 2019 owing to the rising prevalence of tularemia. Further, the rising number of R&D activities, rising awareness among people is boosting regional growth. Europe is expected to account for the second-largest marker share due to increasing infection across the European countries. The Asia Pacific is expected to witness considerable growth over the forecast period.

The Tularemia market is moderately competitive in nature with the presence of international and local players. Key players in the industry focus on new product development and strategic collaborations to expand their product portfolio. Several players invest in R&D activities to develop new drugs and remain competitive in the industry.

Key features of the study:

This proposed research study on Tularemia market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Tularemia market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Tularemia market

Impact of COVID-19 on Tularemia market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Tularemia market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Tularemia market, we have also included competitive landscape and key innovator analysis for the Tularemia market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Tularemia market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Tularemia market on global as well as regional level.

The global Tularemia market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TULAREMIA MARKET KEY PLAYERS

Pfizer Inc.

Zydus Cadila

GlaxoSmithKline plc

Apotex Inc.

Alkem Labs

Sun Pharmaceutical Industries Ltd.

Mylan Pharmaceuticals Inc.

Allergan

Thermo Fisher Scientific Inc.

Piramal Enterprises Ltd.

Bayer AG.

Cipla Inc.

Lupin Pharmaceuticals Inc.

GLOBAL TULAREMIA MARKET, BY TYPE

Glandular Tularemia

Oropharyngeal Tularemia

Ulcer Glandular Tularemia

Pneumatic Tularemia

Others

GLOBAL TULAREMIA MARKET, BY DIAGNOSIS

Immunochemistry

Microscopy

Others

GLOBAL TULAREMIA MARKET, BY DRUGS

Gentamycin

Streptomycin

Ciprofloxacin

Doxycycline

Others

GLOBAL TULAREMIA MARKET, BY END USER

Hospitals & Clinics

Research & Academic Centers

Other

GLOBAL TULAREMIA MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Tularemia Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Type
    • 2.1.2. Market Snippet by Diagnosis
    • 2.1.3. Market Snippet by Drugs
    • 2.1.4. Market Snippet by End User
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. Tularemia Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Tularemia Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tularemia Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tularemia Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Tularemia Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2020 & 2027 (%)
  • 7.2. Glandular Tularemia
  • 7.3. Oropharyngeal Tularemia
  • 7.4. Ulcer Glandular Tularemia
  • 7.5. Pneumatic Tularemia
  • 7.6. Others

8. Tularemia Market - By Diagnosis

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis, 2020 & 2027 (%)
  • 8.2. Immunochemistry
  • 8.3. Microscopy
  • 8.4. Others

9. Tularemia Market - By Drugs

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Drugs, 2020 & 2027 (%)
  • 9.2. Gentamycin
  • 9.3. Streptomycin
  • 9.4. Ciprofloxacin
  • 9.5. Doxycycline
  • 9.6. Others

10. Tularemia Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2020 & 2027 (%)
  • 10.2. Fungal Sepsis
  • 10.3. Bacterial Sepsis
  • 10.4. Other

11. Tularemia Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Drugs, 2016 - 2027, (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.3.12. Rest of Europe
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.3.12.3. Rest of the Europe Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.3.12.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.3.12.5. Rest of the Europe Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.3.12.6. Rest of the Europe Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.4.12. Rest of APAC
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.4.12.3. Rest of APAC Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.4.12.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.4.12.5. Rest of APAC Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.4.12.6. Rest of APAC Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.5.11. Rest of LATAM
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.5.11.5. Rest of LATAM Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.5.11.6. Rest of LATAM Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2016 - 2027 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Drugs, 2016 - 2027 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)

12. Key Vendor Analysis

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Zydus Cadila
    • 12.2.3. GlaxoSmithKline plc
    • 12.2.4. Apotex Inc.
    • 12.2.5. Alkem Labs
    • 12.2.6. Sun Pharmaceutical Industries Ltd.
    • 12.2.7. Mylan Pharmaceuticals Inc.
    • 12.2.8. Allergan
    • 12.2.9. Thermo Fisher Scientific Inc.
    • 12.2.10. Piramal Enterprises Ltd.
    • 12.2.11. Bayer AG.
    • 12.2.12. Cipla Inc.
    • 12.2.13. Lupin Pharmaceuticals Inc.

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Tularemia market: Types Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Types
  • TABLE Global Tularemia market, by Types 2016-2027 (USD Million)
  • TABLE Tularemia market: Diagnosis Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Diagnosis
  • TABLE Global Tularemia market, by Diagnosis 2016-2027 (USD Million)
  • TABLE Tularemia market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Tularemia market, by Region 2016-2027 (USD Million)
  • TABLE North America Tularemia market, by Country, 2016-2027 (USD Million)
  • TABLE North America Tularemia market, by Types, 2016-2027 (USD Million)
  • TABLE North America Tularemia market, by Diagnosis, 2016-2027 (USD Million)
  • TABLE Europe Tularemia market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Tularemia market, by Types, 2016-2027 (USD Million)
  • TABLE Europe Tularemia market, by Diagnosis, 2016-2027 (USD Million)
  • TABLE Asia Pacific Tularemia market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Tularemia market, by Types, 2016-2027 (USD Million)
  • TABLE Asia Pacific Tularemia market, by Diagnosis, 2016-2027 (USD Million)
  • TABLE Latin America Tularemia market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Tularemia market, by Type, 2016-2027 (USD Million)
  • TABLE Latin America Tularemia market, by Diagnosis, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Tularemia market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Tularemia market, by Type, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Tularemia market, by Diagnosis, 2016-2027 (USD Million)

List of Figures

  • FIGURE Tularemia market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Type segment market share analysis, 2020 & 2027
  • FIGURE Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Diagnosis segment market share analysis, 2020 & 2027
  • FIGURE Diagnosis segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Tularemia market share and leading players, 2019
  • FIGURE Europe Tularemia market share and leading players, 2019
  • FIGURE Asia Pacific Tularemia market share and leading players, 2019
  • FIGURE Latin America Tularemia market share and leading players, 2019
  • FIGURE Middle East and Africa Tularemia market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Tularemia market share analysis by country, 2019
  • FIGURE Germany Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Tularemia market share analysis by country, 2019
  • FIGURE India Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Tularemia market share analysis by country, 2019
  • FIGURE Brazil Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Tularemia market share analysis by country, 2019
  • FIGURE Saudi Arabia Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Tularemia market size, forecast and trend analysis, 2016 to 2027 (USD Million)